{"id":210,"date":"2026-08-06T05:08:04","date_gmt":"2026-08-06T05:08:04","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/dental-dso-affiliation-cleveland-ohio\/"},"modified":"2026-08-06T05:08:04","modified_gmt":"2026-08-06T05:08:04","slug":"dental-dso-affiliation-cleveland-ohio","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dental-dso-affiliation-cleveland-ohio\/","title":{"rendered":"DSO Affiliation for Cleveland &#038; Northeast Ohio Dentists"},"content":{"rendered":"<h2 id=\"key-takeaways\">Key Takeaways for Cleveland and Northeast Ohio Dentists<\/h2>\n<ul>\n<li>DSO affiliation has become a common transition path for Northeast Ohio practices with at least $1.5 million in annual revenue, creating a strong institutional buyer market alongside traditional private-buyer options.<\/li>\n<li>Valuation methods differ significantly. DSOs price on adjusted EBITDA multiples, while private buyers usually use a percentage of collections or seller&#8217;s discretionary earnings, which can create valuation gaps of 40\u201380%.<\/li>\n<li>DSO transactions often include complex deal structures with cash at close, rollover equity, and earnouts, plus longer post-close employment commitments than most private sales.<\/li>\n<li>Clinical autonomy after DSO affiliation varies by buyer and contract terms, so owners benefit from evaluating each platform&#8217;s actual operating model instead of relying only on marketing language.<\/li>\n<li>McLerran &amp; Associates helps Cleveland-area practice owners compare DSO and private-buyer options through a competitive bid process that can deliver materially higher valuations. <a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\"><strong>Explore a confidential side-by-side valuation with McLerran &amp; Associates.<\/strong><\/a><\/li>\n<\/ul>\n<h2>How Cleveland Practices Can Compare DSO and Private-Buyer Paths<\/h2>\n<p>The Cleveland and broader Northeast Ohio market sits within one of the most active DSO acquisition corridors in the Midwest. Regional and national institutional buyers pursue profitable general and specialty practices in Ohio, and the private-buyer market for premier practices remains competitive. Owners in the $1.5\u20133 million revenue segment, what McLerran &amp; Associates calls the \u201cVenn diagram middle,\u201d can usually access both markets, so understanding the economics of each path becomes essential.<\/p>\n<p>Valuation mechanics differ sharply between the two paths. <a href=\"https:\/\/privatepracticeresearch.org\/reports\/how-dental-practices-are-valued-2026\" target=\"_blank\" rel=\"noindex nofollow\">A $2 million revenue practice generating $400,000 in adjusted EBITDA can receive $2.4 million to $2.8 million from a DSO buyer at 6x\u20137x EBITDA, versus $1.3 million to $1.7 million from a private buyer pricing at 65\u201385% of collections<\/a>. That spread can reach 40\u201380%, which is why owners in this revenue band often benefit from a formal side-by-side analysis before committing to either lane.<\/p>\n<p>The table below compares the two paths across dimensions that tend to matter most to owners in the $1.5\u20133 million revenue segment. All ranges reflect published market data and serve as educational reference points, not guarantees.<\/p>\n<table>\n<thead>\n<tr>\n<th>Dimension<\/th>\n<th>Private Buyer (Doctor-to-Doctor)<\/th>\n<th>DSO \/ PE Affiliation<\/th>\n<th>Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Valuation method<\/td>\n<td>Percentage of collections or seller&#8217;s discretionary earnings<\/td>\n<td>Multiple of adjusted EBITDA<\/td>\n<td>DSOs use adjusted EBITDA; private buyers focus on SDE<\/td>\n<\/tr>\n<tr>\n<td>Typical valuation range (single-location GP, $1.5\u20133M revenue)<\/td>\n<td><a href=\"https:\/\/privatepracticeresearch.org\/reports\/how-dental-practices-are-valued-2026\" target=\"_blank\" rel=\"noindex nofollow\">65\u201385% of collections<\/a><\/td>\n<td>4x\u20137x adjusted EBITDA<\/td>\n<td>Ranges widen with scale, associate depth, and payer mix<\/td>\n<\/tr>\n<tr>\n<td>Cash at close<\/td>\n<td>Typically majority or all cash<\/td>\n<td>60\u201385% of headline price<\/td>\n<td>Remainder often paid as equity and earnout<\/td>\n<\/tr>\n<tr>\n<td>Rollover equity<\/td>\n<td>Rarely included<\/td>\n<td>15\u201340% of total consideration<\/td>\n<td>Illiquid for 5\u20137 years; upside tied to DSO platform performance<\/td>\n<\/tr>\n<tr>\n<td>Earnout<\/td>\n<td>Uncommon<\/td>\n<td>10\u201325% of total consideration, typically 1\u20133 years<\/td>\n<td>Often tied to EBITDA, collections, or production targets<\/td>\n<\/tr>\n<tr>\n<td>Post-close employment<\/td>\n<td>30\u201390-day transition typical<\/td>\n<td>2\u20135 year employment agreement typical<\/td>\n<td>DSO commitment is longer but can provide ongoing income<\/td>\n<\/tr>\n<tr>\n<td>Clinical autonomy<\/td>\n<td>Buyer assumes full control; seller exits<\/td>\n<td>Varies by platform; clinical decisions remain with the dentist, while scheduling, staffing, and systems migrate to DSO<\/td>\n<td>Often negotiable; depends on specific buyer and contract<\/td>\n<\/tr>\n<tr>\n<td>Transaction timeline<\/td>\n<td>6\u201312 months total<\/td>\n<td>45\u201360-day competitive bid process, plus additional diligence time to closing<\/td>\n<td>McLerran&#8217;s structured process compresses the bid phase<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>EBITDA multiples in the Midwest can be influenced by several recurring factors. Practices with $1 million to $3 million in adjusted EBITDA represent one of the most competitive valuation bands in 2026 and often attract both DSO add-on and emerging-platform buyers. Key drivers that can move a practice toward the higher end of any range include associate depth that reduces owner dependence, hygiene revenue above 30% of collections, a commercial-weighted payer mix, and clean, well-documented financials.<\/p>\n<p>Practices where the owner-doctor performs 90% or more of production can face a meaningful valuation reduction. Heavy Medicaid reliance or shrinking PPO fees can also cap multiples at the lower end of any range. Understanding these valuation ranges is the first step. The second step is running a process that helps you capture the higher end of those ranges through real competition.<\/p>\n<h2>Create Competition for Your Cleveland Practice<\/h2>\n<p>A single-buyer conversation, whether with one DSO or one individual dentist, removes the competitive tension that can push price and terms upward. A practice owner who approaches a single institutional buyer negotiates from a structural disadvantage, because the buyer negotiates transactions every week while the seller may only do this once in a career.<\/p>\n<p>McLerran &amp; Associates addresses this imbalance through a structured, auction-style bid process that typically runs 45\u201360 days and generates around 10 offers per listing. The process begins with a diligence-grade, CPA-led EBITDA analysis, not a quick estimate, which helps control the narrative around the practice&#8217;s profitability before any buyer reviews the numbers. A weak valuation analysis often gets renegotiated down during due diligence, while a defensible one is more likely to hold.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<p>The buyer pool can matter as much as the process itself. Not every institutional buyer is a good partner. McLerran vets buyers before they reach the table and has blacklisted DSOs known for poor post-close environments, including undercapitalized platforms that emerged when capital flowed into the dental space after COVID. The table below outlines the vetted-buyer process.<\/p>\n<table>\n<thead>\n<tr>\n<th>Process Stage<\/th>\n<th>What Happens<\/th>\n<th>Owner Benefit<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>EBITDA analysis &amp; valuation<\/td>\n<td>CPA-led, diligence-grade normalized profit analysis, with every add-back documented<\/td>\n<td>Defensible number that is less likely to be re-traded; helps control the narrative<\/td>\n<\/tr>\n<tr>\n<td>Marketing deck &amp; data room<\/td>\n<td>Confidential practice profile and virtual data room prepared for institutional review<\/td>\n<td>Professional presentation that attracts serious, well-qualified buyers<\/td>\n<\/tr>\n<tr>\n<td>Buyer vetting &amp; blacklisting<\/td>\n<td>Pre-qualified pool screened for financial backing, track record, and seller satisfaction; poorly run DSOs excluded<\/td>\n<td>Only credible buyers reach the table, so owners avoid weak partners<\/td>\n<\/tr>\n<tr>\n<td>Competitive bid process (about 45\u201360 days)<\/td>\n<td>Structured solicitation that generates around 10 offers, with McLerran managing all buyer communications<\/td>\n<td>Competitive tension can improve both price and terms<\/td>\n<\/tr>\n<tr>\n<td>Finalist meetings &amp; selection<\/td>\n<td>Top 1\u20133 buyers advance to in-person meetings or headquarters visits<\/td>\n<td>Owner evaluates fit and culture before committing<\/td>\n<\/tr>\n<tr>\n<td>LOI negotiation &amp; closing<\/td>\n<td>McLerran negotiates terms, defends EBITDA through diligence, and manages the closing process<\/td>\n<td>Agreed value is more likely to hold, and the deal is less likely to collapse late<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>This process has produced outcomes where McLerran clients often receive materially higher valuations than owners who sell on their own, along with a significantly higher close rate than typical industry norms.<\/p>\n<h2>Find the Right DSO or Private-Buyer Fit<\/h2>\n<h3>Compensation Models After Affiliation<\/h3>\n<p>After a DSO affiliation, the selling dentist usually shifts from practice owner to employed clinician, which changes how income is structured. During an initial guarantee period, commonly one to two years, compensation is often set at a fixed amount. After that period, pay typically resets to a production-based model, often a percentage of clinical production.<\/p>\n<p>DSO transactions typically require three-to-five-year employment commitments with compensation reset to employee economics after any initial guarantee period. Owners can benefit from modeling their expected annual income under the post-guarantee structure, not just focusing on the headline deal value, before signing.<\/p>\n<h3>Clinical Autonomy Expectations<\/h3>\n<p>Clinical autonomy after affiliation varies widely. Some DSOs take a light-touch approach to treatment decisions, while others use standardized protocols, preferred materials, staffing models, or production expectations, so outcomes depend heavily on the specific buyer and contract terms. The distinction between clinical and non-clinical authority can be significant.<\/p>\n<p>DSO affiliations generally allow owners to retain clinical decision-making authority within the licensed dental entity, while the DSO assumes non-clinical functions such as HR, billing, marketing, procurement, IT, and compliance. In daily practice, scheduling density, supply formularies, and staffing models can create real constraints even when treatment planning formally remains the dentist&#8217;s responsibility. Reviewing a DSO&#8217;s actual operating model, not just its marketing language, becomes a key part of due diligence.<\/p>\n<h3>Red Flags in DSO Offers<\/h3>\n<p>Several structural features in DSO offers can signal added risk. Three recurring sources of DSO exit regret can include income drops after compensation guarantees expire, non-competes that block later part-time work or new locations, and culture mismatch once the practice operates under DSO systems. Additional red flags include:<\/p>\n<ul>\n<li>Earnout structures with cliff provisions, where missing a target by a small margin forfeits the entire payment, instead of pro-rata (proportional) payouts<\/li>\n<li>Earnout or deal terms that depend on keeping associates in place, where associate departures during transition can trigger clawbacks or even deal collapse<\/li>\n<li>Rollover equity held at the holding-company level without tag-along rights, anti-dilution protections, or regular information rights<\/li>\n<li>Unsupported add-backs, weak collections with stale accounts receivable, and lease or equipment issues that reduce buyer-accepted EBITDA or shift risk back to the seller through adjusted terms<\/li>\n<li>A DSO that cannot provide written answers on equity class and ranking, treatment of seller equity in prior recapitalizations, or associate retention records at previously acquired locations<\/li>\n<\/ul>\n<h2>Maximize Your Outcome With a Cleveland-Focused Team<\/h2>\n<p>McLerran &amp; Associates has completed roughly 2,000 successful practice sales representing approximately $2 billion in closed transaction volume, with more than 10,000 practices evaluated over about 35 years. The firm&#8217;s transaction rate of approximately 85\u201390% reflects a process designed to close, not just to list. That rate matters because a deal that falls apart during diligence can cost the owner months of time, confidentiality exposure, and momentum.<\/p>\n<p>That track record extends to Northeast Ohio, where the Cleveland office is led by Justin Klingshim, who has closed transactions across the state. This local presence matters because the advisor managing a Cleveland-area owner&#8217;s process understands the regional buyer landscape, the specific DSO platforms active in the Midwest corridor, and the nuances of Ohio market conditions, not just national averages.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<p>The firm works both transition paths in roughly equal measure, with approximately 50% private-buyer and 50% DSO or private-equity transactions, which remains uncommon among dental advisors. That balance supports a genuine side-by-side comparison. Owners in the $1.5\u20133 million revenue middle can see their practice valued in both markets before choosing a path, instead of being steered toward whichever lane the advisor prefers.<\/p>\n<p>McLerran represents only sellers. It never represents the buyer. That alignment means every recommendation on timing, structure, buyer selection, and terms is made with the owner&#8217;s interests in mind.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<h2>Frequently Asked Questions<\/h2>\n<h3>How is my practice valued differently by a DSO versus a private buyer?<\/h3>\n<p>As discussed earlier, DSOs typically price practices on adjusted EBITDA multiples, while private buyers often use a percentage of collections or seller&#8217;s discretionary earnings. These two methods can produce very different dollar amounts for the same practice. That difference is why a side-by-side valuation, showing value under both methods, can be a practical way to compare paths. McLerran builds this comparison into each engagement.<\/p>\n<h3>What does rollover equity mean, and how risky is it?<\/h3>\n<p>Rollover equity means a portion of the sale proceeds, commonly 15\u201340% of total consideration, is reinvested as ownership in the DSO&#8217;s parent company rather than paid in cash at closing. That equity is typically illiquid for five to seven years until the platform reaches its next recapitalization or sale event. The potential upside is participation in enterprise-level appreciation if the DSO grows and sells at a higher multiple.<\/p>\n<p>The risk is that the equity becomes a concentrated, illiquid position in a single company, and its value depends entirely on the DSO&#8217;s financial health and the private equity firm&#8217;s ability to execute a successful exit. Owners can evaluate rollover equity the way they would evaluate any investment, by examining the DSO&#8217;s profitability, revenue growth at existing locations, management team quality, and the track record of its private equity backer. McLerran helps owners review that information rather than relying only on the DSO&#8217;s narrative.<\/p>\n<h3>Will I have to keep working after I sell, and for how long?<\/h3>\n<p>In a DSO affiliation, a post-close employment agreement is standard. The typical commitment runs two to five years, with compensation structured as a guaranteed amount for an initial period before resetting to a production-based model. The length and terms are negotiable, and McLerran negotiates them on the owner&#8217;s behalf.<\/p>\n<p>In a private doctor-to-doctor sale, the transition period is usually much shorter, often four to eight weeks, after which the seller exits. Owners who have already reduced their clinical hours or have an associate in place may have more flexibility on the DSO employment term, although a minimum working period is still common in institutional deals.<\/p>\n<h3>How do I know if a DSO is financially stable enough to be a good partner?<\/h3>\n<p>Because up to 40% of a DSO deal can be paid in equity rather than cash, the DSO&#8217;s financial health can directly affect how much of the total consideration the owner ultimately receives. Helpful questions to answer before signing include whether the DSO&#8217;s overall platform is profitable, whether revenue is still growing at the practices it already owns, and whether the private equity firm backing it has a track record of successful dental exits.<\/p>\n<p>Owners can also review what happened to seller equity in prior recapitalizations and what compensation looks like for prior sellers in year two, after the guarantee period expired. McLerran vets buyers against these criteria before they reach the table and has blacklisted DSOs known for poor post-close environments, so owners are more likely to work with well-backed, well-run partners.<\/p>\n<h2>Next Step: Speak With a Cleveland-Focused Sell-Side Advisor<\/h2>\n<p>Demand for premier Northeast Ohio practices remains strong, and valuations for well-documented, profitable practices sit near historic highs. That window may not last indefinitely, and the gap between a well-prepared seller and an unprepared one can be significant. Owners who run an informed, competitive process with a sell-side advisor who works both lanes often achieve clearer economics and better long-term fit than those negotiating alone or through a single-lane broker.<\/p>\n<p>McLerran &amp; Associates&#8217; Cleveland office, led by Justin Klingshim, is available for a free, confidential discovery call to discuss your practice, your goals, and your options, with no obligation and no pressure to sell before you are ready.<\/p>\n<p><em>This article is provided for educational purposes only and does not constitute legal, tax, financial, or investment advice. Every practice and transaction is different. Consult your own attorney, CPA, and financial advisors before making any transition decision.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Exploring DSO affiliation in Cleveland, OH? McLerran helps dentists evaluate valuations, deal structures, and autonomy. Get expert guidance today.<\/p>\n","protected":false},"author":1,"featured_media":209,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-210","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=210"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/210\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/209"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}